Single dose combination of sulfametoxazole/trimethoprim after percutaneous endoscopic gastrostomy
Completed
- Conditions
- Percutaneous endoscopic gastrostomy procedureSurgeryAttention to artificial openings
- Registration Number
- ISRCTN18677736
- Lead Sponsor
- Karolinska Institutet (Sweden)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1. Aged greater than or equal to 15 years, either sex
2. Need for PEG
3. Gives oral consent to the study
4. No contraindication for PEG
Exclusion Criteria
1. Ongoing antibiotic treatment
2. Allergy to study drug or standard treatment
3. Saying no to participation
4. Too sick to be able to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parastomal infection at follow up
- Secondary Outcome Measures
Name Time Method Measured at baseline and follow up:<br>1. Highly sensitive C-reactive protein<br>2. White blood cell count<br>3. Body mass index (BMI)<br>4. Complications